Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management.

Caso F, Tasso M, Chimenti MS, Navarini L, Perricone C, Girolimetto N, Peluso R, Del Puente A, Afeltra A, Perricone R, Punzi L, Scarpa R, Costa L.

Drugs Aging. 2019 Oct;36(10):909-925. doi: 10.1007/s40266-019-00688-3. Review.

PMID:
31250280
2.

Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis".

Caso F, Postiglione L, Covelli B, Ricciardone M, Di Spigna G, Formisano P, D'Esposito V, Girolimetto N, Tasso M, Peluso R, Navarini L, Ciccozzi M, Margiotta DPE, Oliviero F, Afeltra A, Punzi L, Del Puente A, Scarpa R, Costa L.

Clin Rheumatol. 2019 Sep;38(9):2547-2552. doi: 10.1007/s10067-019-04619-w. Epub 2019 May 30.

PMID:
31147798
3.

Effects of antiepileptic therapy on bone mineral status evaluated by phalangeal quantitative ultrasound in pediatric patients with epilepsy and motor impairment.

Terrone G, Gragnaniello V, Esposito A, Del Puente A, Del Giudice E.

Minerva Pediatr. 2019 May 23. doi: 10.23736/S0026-4946.18.05235-0. [Epub ahead of print]

PMID:
31129950
4.

Ultrasonographic Evidence of Predominance of Acute Extracapsular and Chronic Intrasynovial Patterns in 100 Cases of Psoriatic Hand Dactylitis.

Girolimetto N, Macchioni P, Tinazzi I, Costa L, McGonagle D, Peluso R, Del Puente A, Addimanda O, Marchetta A, Possemato N, Tasso M, Salvarani C, Scarpa R, Caso F.

J Rheumatol. 2019 May 15. pii: jrheum.190046. doi: 10.3899/jrheum.190046. [Epub ahead of print]

PMID:
31092722
5.

Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration.

Girolimetto N, Costa L, Mancarella L, Addimanda O, Bottiglieri P, Santelli F, Meliconi R, Peluso R, Del Puente A, Macchioni P, Salvarani C, McGonagle D, Scarpa R, Caso F.

Clin Rheumatol. 2019 Mar;38(3):903-911. doi: 10.1007/s10067-018-4400-z. Epub 2018 Dec 19.

PMID:
30569440
6.

An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis.

Adami G, Rossini M, Bogliolo L, Cantatore FP, Varenna M, Malavolta N, Del Puente A, Muratore M, Orsolini G, Gatti D, Viapiana O.

Mod Rheumatol. 2019 Nov;29(6):1059-1062. doi: 10.1080/14397595.2018.1532622. Epub 2018 Dec 12. No abstract available.

PMID:
30285521
7.

Quantitative Ultrasound of Proximal Phalanxes in Childhood Acute Lymphoblastic Leukemia Survivors.

De Matteo A, Petruzziello F, Parasole R, Esposito A, Mangione A, Giagnuolo G, Menna G, Del Puente A.

J Pediatr Hematol Oncol. 2019 Mar;41(2):140-144. doi: 10.1097/MPH.0000000000001146.

PMID:
29620678
8.

Scores versus clinical profiles in therapeutic decisions: a positive example from the Italian Medicines Agency (AIFA) decisions in the field of osteoporosis.

Del Puente A, Esposito A, Costa L, Caso F, Scarpa R.

Clin Rheumatol. 2018 Mar;37(3):575-578. doi: 10.1007/s10067-018-3995-4. Epub 2018 Jan 29. No abstract available.

PMID:
29380167
9.

Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study.

Caso F, Del Puente A, Oliviero F, Peluso R, Girolimetto N, Bottiglieri P, Foglia F, Benigno C, Tasso M, Punzi L, Scarpa R, Costa L.

Clin Rheumatol. 2018 Mar;37(3):579-586. doi: 10.1007/s10067-017-3975-0. Epub 2018 Jan 8. Review.

PMID:
29313273
10.

Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence.

Costa L, Perricone C, Chimenti MS, Del Puente A, Caso P, Peluso R, Bottiglieri P, Scarpa R, Caso F.

Drugs R D. 2017 Dec;17(4):509-522. doi: 10.1007/s40268-017-0215-7. Review.

11.

Small molecule therapy for managing moderate to severe psoriatic arthritis.

Costa L, Del Puente A, Peluso R, Tasso M, Caso P, Chimenti MS, Sabbatino V, Girolimetto N, Benigno C, Bertolini N, Del Puente A, Perricone R, Scarpa R, Caso F.

Expert Opin Pharmacother. 2017 Oct;18(15):1557-1567. doi: 10.1080/14656566.2017.1378343. Epub 2017 Sep 18. Review.

PMID:
28891341
12.

Psoriatic Disease 10 Years Later.

Scarpa R, Caso F, Costa L, Peluso R, Del Puente A, Olivieri I.

J Rheumatol. 2017 Sep;44(9):1298-1301. doi: 10.3899/jrheum.161402. No abstract available.

PMID:
28864664
13.

Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate.

Costa L, Lubrano E, Ramonda R, Chimenti MS, Vezzù M, Perrotta FM, Del Puente A, Peluso R, Bottiglieri P, Lorenzin M, Sunzini F, Darda MA, Fiocco U, Perricone R, Punzi L, Scarpa R, Caso F.

Clin Rheumatol. 2017 Aug;36(8):1797-1802. doi: 10.1007/s10067-017-3697-3. Epub 2017 Jun 7.

PMID:
28589323
14.

Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.

Rossini M, Viapiana O, Vitiello M, Malavolta N, La Montagna G, Maddali Bongi S, Di Munno O, Nuti R, Manzini CU, Ferri C, Bogliolo L, Mathieu A, Cantatore F, Del Puente A, Muratore M, Grassi W, Frediani B, Saviola G, Delvino P, Mirone L, Ferraccioli G, Tripi G, Piazza I, Gatti D.

Reumatismo. 2017 May 22;69(1):30-39. doi: 10.4081/reumatismo.2017.922.

15.

Vitamin D receptor polymorphisms as tool for early screening of severe bone loss in women patients with rheumatoid arthritis.

Di Spigna G, Del Puente A, Covelli B, Abete E, Varriale E, Salzano S, Postiglione L.

Eur Rev Med Pharmacol Sci. 2016 Nov;20(22):4664-4669.

16.

Clinical effects of mud-bath therapy and oral glucosamine sulfate after 6 months of discontinuation in patients with knee osteoarthritis: results from a randomised, controlled, crossover study.

Caso F, Costa L, Del Puente A, Sorbo D, Balestrieri U, Peluso R, Scarpa R.

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):169. Epub 2016 Sep 7. No abstract available.

PMID:
27749217
17.
18.

Dactylitis in enteropathic spondyloarthritis.

Peluso R, Costa L, Caso F, Del Puente A, Di Minno MN, Manguso F, Castiglione F, Scarpa R.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):842-847. Epub 2016 Apr 15.

PMID:
27087311
19.

Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study.

Peluso R, Caso F, Costa L, Sorbo D, Carraturo N, Di Minno MN, Carraturo F, Oriente A, Balestrieri U, Minicucci A, Del Puente A, Scarpa R.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):618-24. Epub 2016 Apr 6.

PMID:
27050908
20.

Accelerated bone turnover identifies hemiplegic patients at higher risk of demineralization.

Del Puente A, Pappone N, Servodio Iammarrone C, Esposito A, Scarpa R, Costa L, Caso F, Bardoscia A, Del Puente A.

J Biol Regul Homeost Agents. 2016 Jan-Mar;30(1):291-6.

PMID:
27049105
21.

Influenza vaccine with adjuvant on disease activity in psoriatic arthritis patients under anti-TNF-α therapy.

Caso F, Ramonda R, Del Puente A, Darda MA, Cantarini L, Peluso R, Esposito C, Ortolan A, Fiocco U, Punzi L, Scarpa R, Costa L.

Clin Exp Rheumatol. 2016 May-Jun;34(3):507-12. Epub 2016 Mar 11.

PMID:
26967009
22.

Reduced bone mineral density in glycogen storage disease type III: evidence for a possible connection between metabolic imbalance and bone homeostasis.

Melis D, Rossi A, Pivonello R, Del Puente A, Pivonello C, Cangemi G, Negri M, Colao A, Andria G, Parenti G.

Bone. 2016 May;86:79-85. doi: 10.1016/j.bone.2016.02.012. Epub 2016 Feb 23.

PMID:
26924264
23.

Emerging drugs for psoriatic arthritis.

Caso F, Del Puente A, Peluso R, Caso P, Girolimetto N, Del Puente A, Scarpa R, Costa L.

Expert Opin Emerg Drugs. 2016;21(1):69-79. doi: 10.1517/14728214.2016.1146679. Epub 2016 Feb 15. Review.

PMID:
26807876
24.

Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies.

Caso F, Costa L, Del Puente A, Di Minno MN, Lupoli G, Scarpa R, Peluso R.

Ther Adv Chronic Dis. 2015 Nov;6(6):328-38. doi: 10.1177/2040622315608647. Review.

25.

Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis.

Caso F, Lubrano E, Del Puente A, Caso P, Peluso R, Foglia F, Benigno C, Girolimetto N, Bottiglieri P, Scarpa R, Costa L.

Expert Rev Clin Immunol. 2016;12(3):315-31. doi: 10.1586/1744666X.2016.1117941. Epub 2015 Dec 9. Review.

PMID:
26558483
26.

Fragility Fractures in Patients with Psoriatic Arthritis.

Del Puente A, Esposito A, Costa L, Benigno C, Del Puente A, Foglia F, Oriente A, Bottiglieri P, Caso F, Scarpa R.

J Rheumatol Suppl. 2015 Nov;93:36-9. doi: 10.3899/jrheum.150633.

PMID:
26523054
27.

Psoriatic Disease: Clinical Staging.

Scarpa R, Caso F, Costa L, Peluso R, Spanò A, Lubrano E, Del Puente A, Moll JM.

J Rheumatol Suppl. 2015 Nov;93:24-6. doi: 10.3899/jrheum.150629.

PMID:
26523050
28.

PHYSIOPATHOLOGY OF OSTEOPOROSIS: FROM RISK FACTORS ANALYSIS TO TREATMENT.

Del Puente A, Esposito A, Del Puente A, Costa L, Caso F, Scarpa R.

J Biol Regul Homeost Agents. 2015 Jul-Sep;29(3):527-31. Review.

PMID:
26403391
29.

Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis.

Caso F, Costa L, Del Puente A, Rigante D, Selmi C, Fabbroni M, Scarpa R, Galeazzi M, Frediani B, Cantarini L.

Clin Exp Rheumatol. 2015 May-Jun;33(3):411-3. Epub 2015 May 11.

PMID:
25962691
30.

Simple clinical indicators for early psoriatic arthritis detection.

Caso F, Costa L, Atteno M, Del Puente A, Cantarini L, Lubrano E, Scarpa R.

Springerplus. 2014 Dec 22;3:759. doi: 10.1186/2193-1801-3-759. eCollection 2014.

31.

Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.

Caso F, Cantarini L, Morisco F, Del Puente A, Ramonda R, Fiocco U, Lubrano E, Peluso R, Caso P, Galeazzi M, Punzi L, Scarpa R, Costa L.

Expert Opin Biol Ther. 2015 May;15(5):641-50. doi: 10.1517/14712598.2015.1011616. Epub 2015 Feb 4. Review.

PMID:
25652590
32.

Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study.

Costa L, Caso F, Ramonda R, Del Puente A, Cantarini L, Darda MA, Caso P, Lorenzin M, Fiocco U, Punzi L, Scarpa R.

Immunol Res. 2015 Feb;61(1-2):147-53. doi: 10.1007/s12026-014-8595-z.

PMID:
25395342
33.

Thalassemic trait prevalence in patients affected by psoriatic arthritis in anti-TNF treatment.

Atteno M, Costa L, Vitiello M, Caso F, Sarnelli G, Del Puente A, Scarpa R.

Drug Dev Res. 2014 Nov;75 Suppl 1:S20-2. doi: 10.1002/ddr.21188.

PMID:
25381968
34.

Psoriatic arthritis and TNF inhibitors: advances on effectiveness and toxicity.

Caso F, Costa L, Del Puente A, Scarpa R.

Expert Opin Biol Ther. 2015 Jan;15(1):1-2. doi: 10.1517/14712598.2015.973398. Epub 2014 Oct 17.

PMID:
25323456
35.

Efficacy of tocilizumab in a patient with refractory psoriatic arthritis.

Costa L, Caso F, Cantarini L, Del Puente A, Scarpa R, Atteno M.

Clin Rheumatol. 2014 Sep;33(9):1355-7. doi: 10.1007/s10067-014-2603-5. Epub 2014 Apr 8.

PMID:
24705820
36.

Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept.

Costa L, Atteno M, Caso F, Scarpato L, Del Puente A, Scarpa R.

Int J Rheum Dis. 2014 Feb;17(2):219-20. doi: 10.1111/1756-185X.12057. Epub 2013 Apr 4. No abstract available.

PMID:
24576280
37.

The enthesopathy of celiac patients: effects of gluten-free diet.

Atteno M, Costa L, Cozzolino A, Tortora R, Caso F, Del Puente A, Cantarini L, Scarpa R, Ciacci C.

Clin Rheumatol. 2014 Apr;33(4):537-41. doi: 10.1007/s10067-014-2534-1. Epub 2014 Feb 25.

PMID:
24567238
38.

The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection.

Atteno M, Costa L, Matarese A, Caso F, Del Puente A, Cantarini L, Bocchino ML, Sanduzzi A, Scarpa R.

Clin Rheumatol. 2014 Apr;33(4):543-7. doi: 10.1007/s10067-014-2536-z. Epub 2014 Feb 21.

39.

Impaired bone metabolism in glycogen storage disease type 1 is associated with poor metabolic control in type 1a and with granulocyte colony-stimulating factor therapy in type 1b.

Melis D, Pivonello R, Cozzolino M, Della Casa R, Balivo F, Del Puente A, Dionisi-Vici C, Cotugno G, Zuppaldi C, Rigoldi M, Parini R, Colao A, Andria G, Parenti G.

Horm Res Paediatr. 2014;81(1):55-62. doi: 10.1159/000351022. Epub 2013 Dec 21.

PMID:
24401800
40.

Psoriatic arthritis: advances in pharmacotherapy based on molecular target.

Scarpa R, Costa L, Atteno M, Del Puente A, Caso F, Moll JM.

Expert Opin Pharmacother. 2013 Dec;14(17):2311-3. doi: 10.1517/14656566.2013.840292. Epub 2013 Sep 25.

PMID:
24067053
41.

Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients.

Costa L, Caso F, Atteno M, Giannitti C, Spadaro A, Ramonda R, Vezzù M, Del Puente A, Morisco F, Fiocco U, Galeazzi M, Punzi L, Scarpa R.

Clin Rheumatol. 2014 Feb;33(2):273-6. doi: 10.1007/s10067-013-2378-0. Epub 2013 Aug 24.

PMID:
23975363
42.

Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients.

Costa L, Caso F, Atteno M, Del Puente A, Darda MA, Caso P, Ortolan A, Fiocco U, Ramonda R, Punzi L, Scarpa R.

Clin Rheumatol. 2014 Jun;33(6):833-9.

PMID:
23959447
43.

Calcium and vitamin D intakes in children: a randomized controlled trial.

Cosenza L, Pezzella V, Nocerino R, Di Costanzo M, Coruzzo A, Passariello A, Leone L, Savoia M, Del Puente A, Esposito A, Terrin G, Berni Canani R.

BMC Pediatr. 2013 May 23;13:86. doi: 10.1186/1471-2431-13-86.

44.

Prevalence of sarcopenia based on different diagnostic criteria using DEXA and appendicular skeletal muscle mass reference values in an Italian population aged 20 to 80.

Coin A, Sarti S, Ruggiero E, Giannini S, Pedrazzoni M, Minisola S, Rossini M, Del Puente A, Inelmen EM, Manzato E, Sergi G.

J Am Med Dir Assoc. 2013 Jul;14(7):507-12. doi: 10.1016/j.jamda.2013.02.010. Epub 2013 Apr 10.

PMID:
23582341
45.

[The complex interplay between health services administration, health professionals and patients. A challenge to take up].

Del Puente A, Esposito A, Lombardi V, Bova A, Zecca R, Torella R.

Recenti Prog Med. 2013 Feb;104(2):49-53. doi: 10.1701/1241.13703. Review. Italian.

PMID:
23535956
46.

The occurrence of lower limb enthesopathy in coeliac disease patients without clinical signs of articular involvement.

Atteno M, Costa L, Tortora R, Cozzolino A, Del Puente A, Caso F, Sfriso P, Scarpa R, Ciacci C.

Rheumatology (Oxford). 2013 May;52(5):893-7. doi: 10.1093/rheumatology/kes380. Epub 2013 Jan 7.

PMID:
23300330
47.

Trunk and lower limb fat mass evaluated by dual-energy X-ray absorptiometry in a 20- to 80-year-old healthy Italian population.

Coin A, Ruggiero E, Giannini S, Pedrazzoni M, Minisola S, Rossini M, Del Puente A, Inelmen EM, Manzato E, Sergi G.

Ann Nutr Metab. 2012;61(2):151-9.

PMID:
23037332
48.

Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritis.

Varenna M, Manara M, Cantatore FP, Del Puente A, Di Munno O, Malavolta N, Minisola G, Adami S, Sinigaglia L, Rossini M.

Clin Exp Rheumatol. 2012 Sep-Oct;30(5):714-9. Epub 2012 Oct 17.

PMID:
22766134
49.

Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritis.

Sanduzzi A, Bocchino M, Atteno M, Costa L, Ponticiello A, Matarese A, Spanò A, Bruner V, Peluso R, Aquino MM, Del Puente A, Scarpa R.

J Rheumatol Suppl. 2012 Jul;89:82-5. doi: 10.3899/jrheum.120252.

PMID:
22751601
50.

New developments in magnetic resonance imaging of the nail unit.

Soscia E, Sirignano C, Catalano O, Atteno M, Costa L, Caso F, Peluso R, Bruner V, Aquino MM, Del Puente A, Salvatore M, Scarpa R.

J Rheumatol Suppl. 2012 Jul;89:49-53. doi: 10.3899/jrheum.120243.

PMID:
22751592

Supplemental Content

Loading ...
Support Center